Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Ming-Chu Cheng
Introduction
Ming-Chu Cheng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of vaccine development, particularly in combating avian influenza. His innovative work has led to the creation of a unique vaccine composition that combines various viral components to enhance immunogenic response.
Latest Patents
Ming-Chu Cheng holds a patent for a "Bird flu vaccine combination comprising virus-like particles and novel adjuvants." This vaccine composition includes a therapeutically effective amount of an influenza virus-like particle (VLP) that comprises influenza M1, M2, hemagglutinin (HA), and neuraminidase (NA) proteins. Additionally, it incorporates Foot-and-mouth disease virus (FMDV) capsid protein VP3, recombinant FMDV VP3 (rVP3), VP3 peptide, or SUMO VP3, along with alum. The patent outlines the use of this vaccine composition in the manufacture of a medicament aimed at inducing an immunogenic response in subjects in need.
Career Highlights
Ming-Chu Cheng is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has positioned him as a key figure in the field of immunology and vaccine research. His dedication to advancing medical science is evident through his innovative approaches to vaccine development.
Collaborations
Ming-Chu Cheng has collaborated with notable colleagues, including Shu-Mei Liang and Pei-wen Hsiao. These collaborations have further enriched his research and contributed to the advancement of vaccine technologies.
Conclusion
Ming-Chu Cheng's contributions to vaccine development, particularly through his patented innovations, highlight his role as a leading inventor in the field. His work continues to impact public health positively, showcasing the importance of innovation in combating infectious diseases.